查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2127219

2026年全球自動化化療製備與輸注市場報告

Automated Chemotherapy Preparation And Infusion Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，抗癌藥物自動化配藥和給藥市場發展迅速。預計該市場規模將從2025年的13.7億美元成長到2026年的14.8億美元，年複合成長率達8.1%。這一成長主要歸因於全球癌症發病率上升、醫院藥房自動化程度提高、對精準化療劑量需求增加、癌症治療基礎設施擴建以及人們對危險藥物處理安全意識的增強。

預計未來幾年，自動化化療配製和給藥市場將維持強勁成長，年複合成長率（CAGR）將達到8.3%，2030年市場規模將達到20.4億美元。推動這一成長的主要因素包括：對精準腫瘤工作流程的需求不斷成長、對自動化藥房基礎設施的投資增加、個人化療的推廣、門診癌症護理服務的提升，以及對藥物可追溯性和監管合規性的日益重視。預測期內的關鍵趨勢包括：機器人化療配製系統的廣泛應用、對密封藥物配製解決方案的需求不斷成長、更加注重減少化療用藥錯誤、無菌自動化藥房工作流程的擴展，以及對腫瘤藥房職業安全的日益重視。

預計未來幾年，癌症發生率的上升將推動自動化化療配製和輸注市場的成長。癌症是一組以體內異常細胞不受控制地增生和擴散為特徵的疾病。癌症發生率的上升主要是由於全球人口老化。隨著老齡化，基因突變不斷積累，接觸癌症相關風險因子的時間也隨之延長，導致癌症盛行率上升。自動化化療配製和輸注系統透過自動化藥物配製和給藥，減少用藥錯誤，降低醫護人員接觸有害藥物的風險，並提高癌症治療流程的效率，從而增強癌症治療的安全性和有效性。例如，根據總部位於瑞士的世界衛生組織（WHO）的數據，截至2026年7月，全球每年新增癌症病例估計達2,060萬例，死亡人數近1,000萬人。預計到2050年，這一數字將增加至約3500萬。因此，癌症發生率的上升正在推動自動化化療配製和給藥市場的成長。

在自動化化療藥物配製和給藥市場中，領先企業正致力於開發先進的機器人配藥系統，以提高給藥精度、簡化工作流程並減少醫護人員接觸有害藥物的風險。機器人化療配藥系統是一種自動化解決方案，能夠高精度、高一致性地配製化療藥物。這有助於提高給藥準確性、簡化工作流程並減少醫護人員接觸有害藥物的風險。例如，2026年6月，韓國高麗大學安山醫院在其藥房引入了「APOTECA Chemo」機器人化療配藥系統。此系統可根據患者的處方箋自動配製化療藥物，規範整個治療週期的配藥流程，並最大限度地減少醫護人員接觸有害藥物的風險，從而促進自動化化療配藥技術的應用。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球自動化化療配製與輸注市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 清單：主要原料、資源和供應商
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章：全球市場趨勢與策略

  • 關鍵科技與未來趨勢
    • 人工智慧和自主智慧
    • 工業4.0和智慧製造
    • 數位化、雲端運算、巨量資料、網路安全
    • 生物技術、基因組學和精準醫療
    • 物聯網、智慧基礎設施、互聯生態系統
  • 主要趨勢
    • 機器人輔助化療輸送系統的擴展
    • 對封閉式藥物製備解決方案的需求日益成長
    • 人們越來越關注減少化療。
    • 無菌自動化配藥工作流程的擴展
    • 癌症專科藥局對職業安全的日益重視

第5章 終端用戶產業市場分析

  • 腫瘤診所和中心
  • 醫院
  • 專科藥房
  • 癌症研究機構
  • 其他最終用戶

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球自動化化療製備與輸注市場：PESTEL 分析
  • 全球自動化化療配製和輸注市場：規模、對比和成長率分析
  • 全球自動化化療製備與輸注市場表現：規模與成長，2020-2025年
  • 全球自動化化療製備與輸注市場預測：規模與成長，2025-2030年，2035年

第8章：全球市場總規模（TAM）

第9章 市場細分

  • 依產品類型
  • 抗癌藥物自動配藥系統、智慧型輸液幫浦、整合配藥和輸液系統、工作流程管理軟體。
  • 按模式
  • 化療的準備工作，靜脈注射化療
  • 依技術類型
  • 利用人工智慧實現全自動機器人系統、半自動工作站和工作流程自動化。
  • 細胞毒性藥物的分類
  • 烷化劑、抗代謝物、植物生物鹼、抗腫瘤抗生素
  • 最終用戶
  • 癌症治療診所和中心、醫院、專科藥房及其他終端用戶
  • 按類型細分：自動化抗癌藥物分發系統
  • 機器人配藥系統、密封藥物轉移配藥系統、自動化無菌配藥系統、劑量檢驗配藥系統
  • 按類型細分：智慧型輸液泵
  • 正容量智慧型輸液幫浦、注射器式智慧型輸液幫浦、攜帶式智慧型輸液幫浦、多通道智慧型輸液幫浦
  • 按類型細分：一體化製備和注射系統
  • 集中式抗癌藥物製備系統、端到端自動化化療系統、機器人製備和輸注平台以及整合藥房工作流程系統。
  • 按類型細分：工作流程管理軟體
  • 化療處方管理軟體、劑量計算軟體、庫存管理軟體、追溯和合規性管理軟體

第10章 區域與國別分析

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 自動化化療製備與輸注市場：競爭格局與市場佔有率，2024 年
  • 自動化化療製備與輸注市場：公司估值矩陣
  • 自動化化療製備與輸注市場：公司概況
    • Becton Dickinson and Company
    • Baxter International Inc.
    • Fresenius Kabi AG
    • B. Braun SE
    • ICU Medical Inc.

第37章 其他大型企業和創新企業

  • Grifols SA, Terumo Corporation, Omnicell Inc., Moog Inc., Nipro Corporation, Equashield LLC, Loccioni Group Srl, ARxIUM Inc., CODAN Medizinische Gerate GmbH, Micrel Medical Devices SA, Yuyama Co. Ltd., Simplivia Healthcare Ltd., ACE Medical Co. Ltd., Comecer SpA, Fagron NV

第38章：全球市場競爭基準分析與儀錶板

第39章：預計進入市場的新創企業

第40章 重大併購

第41章 具有高市場潛力的國家、細分市場與策略

  • 2030年自動化化療製備與輸注市場：提供新機會的國家
  • 2030年自動化化療製備與輸注市場：蘊藏新機會的細分市場
  • 2030年自動化化療製備與輸注市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第42章附錄

簡介目錄
Product Code: PH5MACPI01_G26Q3

Automated chemotherapy preparation and infusion refer to integrated robotic hardware and closed-system transfer software platforms utilized in oncology pharmacies to accurately compound and safely administer cytotoxic cancer medications. By automating processes such as liquid handling, dilution, and labeling within a sterile enclosure, these systems reduce the risk of pre-analytical dosing errors, improve inventory management, and safeguard pharmacy personnel from direct exposure to hazardous chemical substances.

The primary product categories of automated chemotherapy preparation and infusion include automated chemotherapy compounding systems, smart infusion pumps, integrated preparation and infusion systems, and workflow management software. Automated chemotherapy compounding systems are robotic and automated platforms developed to accurately prepare cytotoxic medications while enhancing dosing accuracy, workflow efficiency, and healthcare worker safety. These solutions support chemotherapy preparation and chemotherapy infusion modalities while utilizing technologies such as fully automated robotic systems, semi-automated workstations, and artificial intelligence-enabled workflow automation. They are used with cytotoxic drug classes including alkylating agents, antimetabolites, plant alkaloids, and antitumor antibiotics and are utilized by end users including oncology clinics and centers, hospitals, specialty pharmacies, and others.

Tariffs are influencing the automated chemotherapy preparation and infusion market by increasing the cost of imported robotic compounding systems, intelligent infusion pumps, precision sensors, semiconductor components, and sterile fluid handling equipment required for automated oncology workflows. This is increasing manufacturing and procurement expenses while slowing the adoption of automated chemotherapy compounding systems, integrated preparation and infusion platforms, and workflow management software. Hardware-intensive product categories are experiencing the greatest impact, particularly across North America, Europe, and Asia-Pacific because of global supply chain reliance. However, tariffs are also promoting domestic manufacturing, regional supplier diversification, and stronger investment in local medical device and healthcare automation production, strengthening long-term market resilience.

The automated chemotherapy preparation and infusion market research report is one of a series of new reports from The Business Research Company that provides automated chemotherapy preparation and infusion market statistics, including automated chemotherapy preparation and infusion industry global market size, regional shares, competitors with a automated chemotherapy preparation and infusion market share, detailed automated chemotherapy preparation and infusion market segments, market trends and opportunities, and any further data you may need to thrive in the automated chemotherapy preparation and infusion industry. This automated chemotherapy preparation and infusion market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The automated chemotherapy preparation and infusion market size has grown strongly in recent years. It will grow from $1.37 billion in 2025 to $1.48 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to rising global cancer incidence, increasing adoption of hospital pharmacy automation, growing demand for accurate chemotherapy dosing, expanding oncology treatment infrastructure, increasing awareness of hazardous drug handling safety.

The automated chemotherapy preparation and infusion market size is expected to see strong growth in the next few years. It will grow to $2.04 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to increasing demand for precision oncology workflows, growing investment in automated pharmacy infrastructure, rising adoption of personalized chemotherapy treatment, expanding outpatient cancer treatment services, increasing focus on medication traceability and regulatory compliance. Major trends in the forecast period include increasing adoption of robotic chemotherapy compounding systems, growing demand for closed system drug preparation solutions, rising focus on reducing chemotherapy medication errors, expanding implementation of sterile automated pharmacy workflows, increasing emphasis on occupational safety in oncology pharmacies.

The increasing cancer incidence is anticipated to drive the growth of the automated chemotherapy preparation and infusion market in the coming years. Cancer refers to a group of diseases characterized by the uncontrolled growth and spread of abnormal cells throughout the body. The rising incidence of cancer is largely attributed to the aging global population, as advancing age contributes to the accumulation of genetic mutations and prolonged exposure to cancer-related risk factors, leading to a greater prevalence of cancer. Automated chemotherapy preparation and infusion systems enhance the safety and efficiency of cancer treatment by automating drug preparation and administration, reducing medication errors, limiting healthcare worker exposure to hazardous drugs, and improving oncology workflow efficiency. For instance, in July 2026, according to the World Health Organization (WHO), a Switzerland-based health agency, annual new cancer cases reached an estimated 20.6 million worldwide, with nearly 10 million deaths, and this number is expected to increase to approximately 35 million cases by 2050. Therefore, the increasing cancer incidence is contributing to the growth of the automated chemotherapy preparation and infusion market.

Leading companies operating in the automated chemotherapy preparation and infusion market are focusing on developing advanced robotic compounding systems to improve medication accuracy, enhance workflow efficiency, and reduce healthcare workers' exposure to hazardous drugs. Robotic chemotherapy compounding systems are automated solutions that prepare chemotherapy drugs with high precision and consistency. They improve dosing accuracy, enhance workflow efficiency, and reduce healthcare workers' exposure to hazardous drugs. For example, in June 2026, Korea University Ansan Hospital, a South Korea-based healthcare organization, introduced the APOTECA Chemo robotic chemotherapy compounding system in its Department of Pharmacy. The system automates the preparation of chemotherapy medications based on individual patient prescriptions, standardizes the compounding process across treatment cycles, and minimizes healthcare workers' exposure to hazardous drugs, supporting the adoption of automated chemotherapy preparation technologies.

In June 2024, Equashield, a US-based developer of the EQUASHIELD Pro automated chemotherapy compounding robot, entered into a partnership with Pharmacy Stars to improve safety standards and regulatory adherence across healthcare operations. The collaboration combined automated hazardous drug compounding robotics with digital compliance management software to optimize chemotherapy preparation processes. As a result, it improved real-time tracking, safety validation, and record-keeping capabilities, enhancing the precision and regulatory compliance of automated oncology compounding workflows. Pharmacy Stars is a US-based provider of enterprise pharmacy compliance, regulatory management, and quality assurance software.

Major companies operating in the automated chemotherapy preparation and infusion market report are Becton Dickinson and Company, Baxter International Inc., Fresenius Kabi AG, B. Braun Melsungen AG, ICU Medical Inc., Grifols S.A., Terumo Corporation, Omnicell Inc., Moog Inc., Nipro Corporation, Equashield LLC, Loccioni Group S.r.l., ARxIUM Inc., CODAN Medizinische Gerate GmbH, Micrel Medical Devices S.A., Yuyama Co. Ltd., Simplivia Healthcare Ltd., ACE Medical Co. Ltd., Comecer S.p.A., Fagron NV

North America was the dominant region in the automated chemotherapy preparation and infusion market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the automated chemotherapy preparation and infusion market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the automated chemotherapy preparation and infusion market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The automated chemotherapy preparation and infusion market includes revenues earned by entities by providing services such as robotic chemotherapy compounding, automated dose verification, infusion therapy management, equipment maintenance, and software integration. The market value includes the value of related goods sold by the service provider or included within the service offering. The automated chemotherapy preparation and infusion market also includes sales ofautomated chemotherapy compounding systems, robotic chemotherapy preparation systems, automated drug compounding robots, closed-system transfer devices (CSTDs) and automated infusion pumps. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Automated Chemotherapy Preparation And Infusion Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses automated chemotherapy preparation and infusion market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for automated chemotherapy preparation and infusion ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The automated chemotherapy preparation and infusion market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Automated Chemotherapy Compounding Systems; Smart Infusion Pumps; Integrated Preparation And Infusion Systems; Workflow Management Software
  • 2) By Modality: Chemotherapy Preparation; Chemotherapy Infusion
  • 3) By Technology Type: Fully Automated Robotic Systems; Semi Automated Workstations; Artificial Intelligence Enabled Workflow Automation
  • 4) By Cytotoxic Drug Class: Alkylating Agents; Antimetabolites; Plant Alkaloids; Antitumor Antibiotics
  • 5) By End User: Oncology Clinics And Centers; Hospitals; Specialty Pharmacies; Other End Users
  • Subsegments:
  • 1) By Automated Chemotherapy Compounding Systems: Robotic Compounding Systems; Closed System Drug Transfer Compounding Systems; Automated Sterile Compounding Systems; Dose Verification Compounding Systems
  • 2) By Smart Infusion Pumps: Volumetric Smart Infusion Pumps; Syringe Smart Infusion Pumps; Ambulatory Smart Infusion Pumps; Multi Channel Smart Infusion Pumps
  • 3) By Integrated Preparation And Infusion Systems: Centralized Oncology Preparation Systems; End To End Chemotherapy Automation Systems; Robotic Preparation And Infusion Platforms; Integrated Pharmacy Workflow Systems
  • 4) By Workflow Management Software: Chemotherapy Order Management Software; Dose Calculation Software; Inventory Management Software; Traceability And Compliance Software
  • Companies Mentioned: Becton Dickinson and Company; Baxter International Inc.; Fresenius Kabi AG; B. Braun Melsungen AG; ICU Medical Inc.; Grifols S.A.; Terumo Corporation; Omnicell Inc.; Moog Inc.; Nipro Corporation; Equashield LLC; Loccioni Group S.r.l.; ARxIUM Inc.; CODAN Medizinische Gerate GmbH; Micrel Medical Devices S.A.; Yuyama Co. Ltd.; Simplivia Healthcare Ltd.; ACE Medical Co. Ltd.; Comecer S.p.A.; Fagron NV
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Automated Chemotherapy Preparation And Infusion Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Automated Chemotherapy Preparation And Infusion Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Automated Chemotherapy Preparation And Infusion Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Automated Chemotherapy Preparation And Infusion Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Industry 4.0 & Intelligent Manufacturing
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Biotechnology, Genomics & Precision Medicine
    • 4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Robotic Chemotherapy Compounding Systems
    • 4.2.2 Growing Demand For Closed System Drug Preparation Solutions
    • 4.2.3 Rising Focus On Reducing Chemotherapy Medication Errors
    • 4.2.4 Expanding Implementation Of Sterile Automated Pharmacy Workflows
    • 4.2.5 Increasing Emphasis On Occupational Safety In Oncology Pharmacies

5. Automated Chemotherapy Preparation And Infusion Market Analysis Of End Use Industries

  • 5.1 Oncology Clinics And Centers
  • 5.2 Hospitals
  • 5.3 Specialty Pharmacies
  • 5.4 Cancer Research Institutes
  • 5.5 Other End Users

6. Automated Chemotherapy Preparation And Infusion Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Automated Chemotherapy Preparation And Infusion Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Automated Chemotherapy Preparation And Infusion PESTEL Analysis (Political, Economical, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Automated Chemotherapy Preparation And Infusion Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Automated Chemotherapy Preparation And Infusion Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Automated Chemotherapy Preparation And Infusion Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Automated Chemotherapy Preparation And Infusion Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Automated Chemotherapy Preparation And Infusion Market Segmentation

  • 9.1. Global Automated Chemotherapy Preparation And Infusion Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Automated Chemotherapy Compounding Systems, Smart Infusion Pumps, Integrated Preparation And Infusion Systems, Workflow Management Software
  • 9.2. Global Automated Chemotherapy Preparation And Infusion Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Chemotherapy Preparation, Chemotherapy Infusion
  • 9.3. Global Automated Chemotherapy Preparation And Infusion Market, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Fully Automated Robotic Systems, Semi Automated Workstations, Artificial Intelligence Enabled Workflow Automation
  • 9.4. Global Automated Chemotherapy Preparation And Infusion Market, Segmentation By Cytotoxic Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Alkylating Agents, Antimetabolites, Plant Alkaloids, Antitumor Antibiotics
  • 9.5. Global Automated Chemotherapy Preparation And Infusion Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Oncology Clinics And Centers, Hospitals, Specialty Pharmacies, Other End Users
  • 9.6. Global Automated Chemotherapy Preparation And Infusion Market, Sub-Segmentation Of Automated Chemotherapy Compounding Systems, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Robotic Compounding Systems, Closed System Drug Transfer Compounding Systems, Automated Sterile Compounding Systems, Dose Verification Compounding Systems
  • 9.7. Global Automated Chemotherapy Preparation And Infusion Market, Sub-Segmentation Of Smart Infusion Pumps, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Volumetric Smart Infusion Pumps, Syringe Smart Infusion Pumps, Ambulatory Smart Infusion Pumps, Multi Channel Smart Infusion Pumps
  • 9.8. Global Automated Chemotherapy Preparation And Infusion Market, Sub-Segmentation Of Integrated Preparation And Infusion Systems, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Centralized Oncology Preparation Systems, End To End Chemotherapy Automation Systems, Robotic Preparation And Infusion Platforms, Integrated Pharmacy Workflow Systems
  • 9.9. Global Automated Chemotherapy Preparation And Infusion Market, Sub-Segmentation Of Workflow Management Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Chemotherapy Order Management Software, Dose Calculation Software, Inventory Management Software, Traceability And Compliance Software

10. Automated Chemotherapy Preparation And Infusion Market Regional And Country Analysis

  • 10.1. Global Automated Chemotherapy Preparation And Infusion Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Automated Chemotherapy Preparation And Infusion Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Automated Chemotherapy Preparation And Infusion Market

  • 11.1. Asia-Pacific Automated Chemotherapy Preparation And Infusion Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Automated Chemotherapy Preparation And Infusion Market, Segmentation By Product Type, Segmentation By Modality, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Automated Chemotherapy Preparation And Infusion Market

  • 12.1. China Automated Chemotherapy Preparation And Infusion Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Automated Chemotherapy Preparation And Infusion Market, Segmentation By Product Type, Segmentation By Modality, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Automated Chemotherapy Preparation And Infusion Market

  • 13.1. India Automated Chemotherapy Preparation And Infusion Market, Segmentation By Product Type, Segmentation By Modality, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Automated Chemotherapy Preparation And Infusion Market

  • 14.1. Japan Automated Chemotherapy Preparation And Infusion Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Automated Chemotherapy Preparation And Infusion Market, Segmentation By Product Type, Segmentation By Modality, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Automated Chemotherapy Preparation And Infusion Market

  • 15.1. Australia Automated Chemotherapy Preparation And Infusion Market, Segmentation By Product Type, Segmentation By Modality, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Automated Chemotherapy Preparation And Infusion Market

  • 16.1. Indonesia Automated Chemotherapy Preparation And Infusion Market, Segmentation By Product Type, Segmentation By Modality, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Automated Chemotherapy Preparation And Infusion Market

  • 17.1. South Korea Automated Chemotherapy Preparation And Infusion Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Automated Chemotherapy Preparation And Infusion Market, Segmentation By Product Type, Segmentation By Modality, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Automated Chemotherapy Preparation And Infusion Market

  • 18.1. Taiwan Automated Chemotherapy Preparation And Infusion Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Automated Chemotherapy Preparation And Infusion Market, Segmentation By Product Type, Segmentation By Modality, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Automated Chemotherapy Preparation And Infusion Market

  • 19.1. South East Asia Automated Chemotherapy Preparation And Infusion Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Automated Chemotherapy Preparation And Infusion Market, Segmentation By Product Type, Segmentation By Modality, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Automated Chemotherapy Preparation And Infusion Market

  • 20.1. Western Europe Automated Chemotherapy Preparation And Infusion Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Automated Chemotherapy Preparation And Infusion Market, Segmentation By Product Type, Segmentation By Modality, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Automated Chemotherapy Preparation And Infusion Market

  • 21.1. UK Automated Chemotherapy Preparation And Infusion Market, Segmentation By Product Type, Segmentation By Modality, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Automated Chemotherapy Preparation And Infusion Market

  • 22.1. Germany Automated Chemotherapy Preparation And Infusion Market, Segmentation By Product Type, Segmentation By Modality, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Automated Chemotherapy Preparation And Infusion Market

  • 23.1. France Automated Chemotherapy Preparation And Infusion Market, Segmentation By Product Type, Segmentation By Modality, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Automated Chemotherapy Preparation And Infusion Market

  • 24.1. Italy Automated Chemotherapy Preparation And Infusion Market, Segmentation By Product Type, Segmentation By Modality, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Automated Chemotherapy Preparation And Infusion Market

  • 25.1. Spain Automated Chemotherapy Preparation And Infusion Market, Segmentation By Product Type, Segmentation By Modality, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Automated Chemotherapy Preparation And Infusion Market

  • 26.1. Eastern Europe Automated Chemotherapy Preparation And Infusion Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Automated Chemotherapy Preparation And Infusion Market, Segmentation By Product Type, Segmentation By Modality, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Automated Chemotherapy Preparation And Infusion Market

  • 27.1. Russia Automated Chemotherapy Preparation And Infusion Market, Segmentation By Product Type, Segmentation By Modality, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Automated Chemotherapy Preparation And Infusion Market

  • 28.1. North America Automated Chemotherapy Preparation And Infusion Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Automated Chemotherapy Preparation And Infusion Market, Segmentation By Product Type, Segmentation By Modality, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Automated Chemotherapy Preparation And Infusion Market

  • 29.1. USA Automated Chemotherapy Preparation And Infusion Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Automated Chemotherapy Preparation And Infusion Market, Segmentation By Product Type, Segmentation By Modality, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Automated Chemotherapy Preparation And Infusion Market

  • 30.1. Canada Automated Chemotherapy Preparation And Infusion Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Automated Chemotherapy Preparation And Infusion Market, Segmentation By Product Type, Segmentation By Modality, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Automated Chemotherapy Preparation And Infusion Market

  • 31.1. South America Automated Chemotherapy Preparation And Infusion Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Automated Chemotherapy Preparation And Infusion Market, Segmentation By Product Type, Segmentation By Modality, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Automated Chemotherapy Preparation And Infusion Market

  • 32.1. Brazil Automated Chemotherapy Preparation And Infusion Market, Segmentation By Product Type, Segmentation By Modality, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Automated Chemotherapy Preparation And Infusion Market

  • 33.1. Middle East Automated Chemotherapy Preparation And Infusion Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Automated Chemotherapy Preparation And Infusion Market, Segmentation By Product Type, Segmentation By Modality, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Automated Chemotherapy Preparation And Infusion Market

  • 34.1. Africa Automated Chemotherapy Preparation And Infusion Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Automated Chemotherapy Preparation And Infusion Market, Segmentation By Product Type, Segmentation By Modality, Segmentation By Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Automated Chemotherapy Preparation And Infusion Market Regulatory and Investment Landscape

36. Automated Chemotherapy Preparation And Infusion Market Competitive Landscape And Company Profiles

  • 36.1. Automated Chemotherapy Preparation And Infusion Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Automated Chemotherapy Preparation And Infusion Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Automated Chemotherapy Preparation And Infusion Market Company Profiles
    • 36.3.1. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. B. Braun SE Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. ICU Medical Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Automated Chemotherapy Preparation And Infusion Market Other Major And Innovative Companies

  • Grifols S.A., Terumo Corporation, Omnicell Inc., Moog Inc., Nipro Corporation, Equashield LLC, Loccioni Group S.r.l., ARxIUM Inc., CODAN Medizinische Gerate GmbH, Micrel Medical Devices S.A., Yuyama Co. Ltd., Simplivia Healthcare Ltd., ACE Medical Co. Ltd., Comecer S.p.A., Fagron NV

38. Global Automated Chemotherapy Preparation And Infusion Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Automated Chemotherapy Preparation And Infusion Market

41. Automated Chemotherapy Preparation And Infusion Market High Potential Countries, Segments and Strategies

  • 41.1 Automated Chemotherapy Preparation And Infusion Market In 2030 - Countries Offering Most New Opportunities
  • 41.2 Automated Chemotherapy Preparation And Infusion Market In 2030 - Segments Offering Most New Opportunities
  • 41.3 Automated Chemotherapy Preparation And Infusion Market In 2030 - Growth Strategies
    • 41.3.1 Market Trend Based Strategies
    • 41.3.2 Competitor Strategies

42. Appendix

  • 42.1. Abbreviations
  • 42.2. Currencies
  • 42.3. Historic And Forecast Inflation Rates
  • 42.4. Research Inquiries
  • 42.5. The Business Research Company
  • 42.6. Copyright And Disclaimer